Mark Borowsky, CIO, Novartis Institutes for Biomedical Research
An overview of several use-cases in ‘AI-ML-NLP’ solutions, and how to set up rapid POCs and experimentation for quick wins. Use cases range from applying robotic process automation and classification techniques in self-serve IT infrastructure, intelligent document processing, general natural language generation dashboard, natural language processing techniques in clinical and non-clinical settings, evaluating several models in summarization and extraction spaces, building conversational AI framework and chatbots, testing and trying vendor solutions (AWS, Azure, Watson, Startups etc.). and many more. Please attend if you can, or contact the speaker through his LinkedIn or twitter profile for any questions.
Typical informatics systems and instrument analysis data don’t provide the full context for your protocols and methods. With recent focus on digitalization to enable productivity/ quality improvements and decision making, it is critical to get the complete context for these results. A fully connected lab is essential to enable this but every lab faces challenges in achieving this with plethora of protocols and instruments, instrument software and applications in place. In this talk, we will discuss the typical challenges faced and an approach to overcome these challenges through our accelerator solution.
We are entering a digital transformation, where paperless processes and modern cloud solutions are now becoming the norm. The digital era that we now live in is rapidly changing the way we operate in laboratory settings by optimizing equipment usage, improving workflows, reducing waste, and delivering cost savings and faster turnaround times. A real case will help to understand the benefits of a digitally optimized lab operation set up and the different tools that are used to achieve these goals, with a focus on equipment management and scheduling.
Todd Maloney, Executive Director, Eli Lilly & Co
James Vergis, Secretariat, Enabling Technologies Consortium
Matthew Bahr, Scientific Team Leader, GSK
Daniel Patience Head of Chemical Engineering, Small MoleculesBiogen